SynthesisOrphanet journal of rare diseases2024

Safety and efficacy of omaveloxolone v/s placebo for the treatment of Friedreich's ataxia in patients aged more than 16 years: a systematic review.

Ankita Umrao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.